7H-Furo[3,2-g][1]benzopyran-7-one, 9-[(2R)-3-hydroxy-2-[(2R)-2-hydroxy-1,1-dimethyl-3-[(7-oxo-7H-furo[3,2-g][1]benzopyran-9-yl)oxy]propoxy]-3-methylbutoxy]- - Names and Identifiers
7H-Furo[3,2-g][1]benzopyran-7-one, 9-[(2R)-3-hydroxy-2-[(2R)-2-hydroxy-1,1-dimethyl-3-[(7-oxo-7H-furo[3,2-g][1]benzopyran-9-yl)oxy]propoxy]-3-methylbutoxy]- - Physico-chemical Properties
Molecular Formula | C32H30O11
|
Molar Mass | 590.57 |
Density | 1.400±0.06 g/cm3(Predicted) |
Boling Point | 798.9±60.0 °C(Predicted) |
pKa | 13.80±0.20(Predicted) |
Storage Condition | 2-8℃ |
7H-Furo[3,2-g][1]benzopyran-7-one, 9-[(2R)-3-hydroxy-2-[(2R)-2-hydroxy-1,1-dimethyl-3-[(7-oxo-7H-furo[3,2-g][1]benzopyran-9-yl)oxy]propoxy]-3-methylbutoxy]- - Introduction
Rivulobirin E is an organic compound, which is a polycyclic aromatic compound. Its chemical formula is C15H20O2 and its molecular weight is 232.32g/mol.
Rivulobirin E has some important biological activities, such as antibacterial, antiviral and antitumor effects. It has wide application potential in the field of drug research and development.
The method for preparing Rivulobirin E is relatively complicated and is generally carried out by organic synthesis. The specific synthetic route may vary depending on the purpose and conditions of the study.
Regarding the safety information of Rivulobirin E, there is still a lack of relevant data. However, as an organic compound, it should follow general safety practices when used in drug development, including wearing protective equipment when handling, avoiding contact with skin or inhaling its dust or gas, properly stored and disposed. Before using Rivulobirin E, further research and evaluation should be carried out, and relevant chemical safety manuals and operational guidelines should be consulted.
Last Update:2024-04-09 19:05:57